Broker tips 90% upside for this ASX materials stock!

This materials stock is on the rise.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Bell Potter identifies Viridis for significant growth, highlighting its momentum with a 294.29% rise this year.
  • Viridis' acquisition of REE rights to the Colossus IAC Project in Brazil boosts potential.
  • Bell Potter increases Viridis' price target to $2.65 from $1.55, indicating a 92% upside, while maintaining a speculative buy rating on the stock. 

ASX materials stocks have largely performed well in 2025. 

The team at Bell Potter has identified Viridis Mining and Minerals Ltd (ASX: VMM) as one set for increased growth. 

It is a resource exploration and development company with assets in Brazil, Canada, and Australia.

This year, it has already flown 294.29% higher. 

For context, the S&P/ASX 200 Materials Index (ASX: XMJ) is up 20% in the same span. 

At the time of writing, this ASX-listed materials stock is trading at $1.38 per share. 

The team at Bell Potter has a speculative buy rating on Viridis shares. 

Let's see what is behind the optimism. 

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.

Image source: Getty Images

Momentum building

In August of 2023, Viridis acquired 100% Rare Earth Element (REE) rights to the Colossus IAC (Ionic Adsorption Clay) Project.

The Colossus IAC REE Project is located in the State of Minas Gerais, Brazil, and comprises a total of 228.62km2 licenses within and around the prolific Poços De Caldas Alkaline Complex.

In a report from Bell Potter yesterday, the broker highlighted strong near-term catalysts and continued support from secular demand for rare earths, maintaining a positive outlook on Viridis.

Noteably, Bell Potter recently visited Vulcan Minerals' Colossus rare earth project in Brazil, where they reviewed the regional geology, proposed processing design, metallurgical results, permitting progress, ESG considerations, and the development of the demonstration plant.

The broker highlighted that processing risks appear lower than for peers due to favourable mineralogy and local operational experience, and there could be upside to both payability (above 70%) and operating costs (currently estimated at US$11.8 per tonne, compared with Bell Potter's estimate of US$15.2 per tonne).

Press filter risks are likely to be less concerning than peers due to favourable mineralogy, and existing experience from current operators within the Caldeira, whilst opportunities exist beyond our base case for payabilities (BPe 70%) and Opex (BPe US$15.2/t ore processed, VMM US$11.8/t).

Upside for ASX materials stock

Bell Potter maintains its speculative buy rating on this ASX materials stock. 

The broker also increased its price target to $2.65 (previously $1.55). 

The updated price target from Bell Potter indicates an upside of approximately 92%. 

Our recommendation and valuation are based on a 40% risked assessment of estimated FCF for the Colossus ionic adsorption clay project in Brazil. Near-term catalysts, along with a strong secular tailwind, are likely to continue to support VMM.

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »

An oil refinery worker stands in front of an oil rig with his arms crossed and a smile on his face.
Energy Shares

4 ASX 200 energy shares rated buys

ASX 200 energy shares have skyrocketed 14% over the past month.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Buy, hold, sell: BHP, CBA, and Pro Medicus shares

Are analysts bullish on the big names? Let's find out.

Read more »